Cyclacel Pharmaceuticals, Inc. CYCC
6.37 0.00 0.00%
At close · Sep 11
52-week range unavailable
- Open
- 6.76
- Prev close
- 6.37
- Mkt cap
- 10.61M
- Vol
- 219.91K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.10
- High
- 6.96
- Forward P/E
- -0.16
- Beta
- 0.56
- Short ratio
- 0.03
- Inst. own
- 18.03%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.5528
- 200-d avg
- 1.41
- 1y target
- 1.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for CYCC has not been loaded yet. Try again in a moment.
Altman Z-Score
-71.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -15.1×
P/S 286×
P/B 31.2×
P/FCF -44.7×
EV/EBITDA 41987×
EV/Sales 281×
FCF Yield -2.2%
Gross Margin 18.5%
Operating Margin -1128.1%
Net Margin -401.3%
ROE -43.8%
ROIC -122.7%
ROA -36.6%
Revenue 1637.2%
Operating Income 29.8%
EPS (diluted) -374.3%
Free Cash Flow 40.3%
Current Ratio 4.7×
Quick Ratio 3.7×
Debt / Equity 0.0×
Net Debt / EBITDA -701×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio -2.0%
Annual · latest fiscal year ends 2025-12-31